SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the ...
Mixed options sentiment in Moderna (MRNA), with shares down 2c near $26.73. Options volume relatively light with 20k contracts traded and calls ...